Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies

Androgen deprivation therapy (ADT) plays an important role in the contemporary management of prostate cancer (PCa) across various stages of the disease. While ADT remains a highly effective treatment for PCa, it is not curative, and its use is associated with significant adverse events that span across various organ systems.

Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies – Executive summary Journal Articles